TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36351989

Group type: EXPERIMENTAL
Intervention: Knee-powered lower limb exoskeleton (ABLE Exoskeleton)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive orthoses (KAFOs)
Number of subjects: 10
Study: 32706061

Group type: EXPERIMENTAL
Intervention: Major Trauma Clinical Pathway (MTCP) monitoring system
Number of subjects: 998240
Study: 36217135

Group type: EXPERIMENTAL
Intervention: Mobile health application (8-week intervention)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Waiting control group (no intervention)
Number of subjects: 130
Study: 33405987

Group type: EXPERIMENTAL
Intervention: Digital interactive multimedia tutorial (DIMT; 45-minute narrated, interactive module)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Lecture (45-minute lecture by a faculty member)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Independent study (45 minutes to read a highlighted textbook chapter)
Number of subjects: 42
Study: 32028859

Group type: EXPERIMENTAL
Intervention: AFT/FIS workshop
Number of subjects: 58

Group type: COMPARATOR
Intervention: Demonstration training (DT) workshop
Number of subjects: 58
Study: 34776422

Group type: EXPERIMENTAL
Intervention: 10Hz frequency rTMS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 5Hz frequency rTMS
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1Hz frequency rTMS
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 90
Study: 33023877

Group type: EXPERIMENTAL
Intervention: TCPRLink
Number of subjects: 186

Group type: COMPARATOR
Intervention: T-CPR
Number of subjects: 186
Study: 34350594

Group type: EXPERIMENTAL
Intervention: Digital Bodies intervention
Number of subjects: 290

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 290
Study: 33887308

Group type: EXPERIMENTAL
Intervention: Foraminal enlargement (FE)
Number of subjects: 140
Study: 34666302

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg three times a day for 10 days
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pentoxifylline (PTX) and Placebo
Number of subjects: 72
Study: 33600687

Group type: EXPERIMENTAL
Intervention: Inhaled Human Insulin (Exubera®)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Subcutaneous Insulin
Number of subjects: 121
Study: 34311704

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 392
Study: 33075257

Group type: EXPERIMENTAL
Intervention: High-dose 24-hour infusion of tranexamic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35356803

Group type: EXPERIMENTAL
Intervention: Febuxostat (F group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Benzbromarone (B group)
Number of subjects: 21
Study: 35201829

Group type: EXPERIMENTAL
Intervention: Illegal tobacco purchases with fines (ITP_F)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Illegal tobacco purchases with fines, criminal record, and negative public exposure (ITP_F + CR + NPE)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Legal tobacco purchases (LTP)
Number of subjects: 93
Study: 33536398

Group type: EXPERIMENTAL
Intervention: Pemafibrate 0.025-0.2 mg BID
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Fenofibrate 100 mg QD
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 32419119

Group type: EXPERIMENTAL
Intervention: Parenting intervention integrated with primary health care, including a parenting pamphlet and two parenting training sessions
Number of subjects: 168
Study: 34665865

Group type: EXPERIMENTAL
Intervention: LD-RTX plus ATRA
Number of subjects: 168

Group type: COMPARATOR
Intervention: LD-RTX monotherapy
Number of subjects: 168
Study: 33107490

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 33829894

Group type: EXPERIMENTAL
Intervention: Comprehensive Health Education (CHE)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Standard Health Education (SHE)
Number of subjects: 428
Study: 33641504

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program over 9 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: No-exercise group
Number of subjects: 26
Study: 32961848

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) for 6 months
Number of subjects: 26

Group type: COMPARATOR
Intervention: Passive control group (CG)
Number of subjects: 26
Study: 36333954

Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (5-mg intravenously)
Number of subjects: 76
Study: 34187126

Group type: EXPERIMENTAL
Intervention: Olive oil massage for lower back and lower leg during hemodialysis for eight weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Olive oil massage
Number of subjects: 200
Study: 33595792

Group type: EXPERIMENTAL
Intervention: Amikacin liposome inhalation suspension (ALIS) 590 mg once daily
Number of subjects: 53
Study: 33555430

Group type: EXPERIMENTAL
Intervention: Intraoperative intestinal isolation bag
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care (no isolation bag)
Number of subjects: 92
Study: 33789646

Group type: EXPERIMENTAL
Intervention: Perio Slim (PS) scaler tip
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional scaler tip
Number of subjects: 30
Study: 33499025

Group type: EXPERIMENTAL
Intervention: 25 g β-Lactoglobulin (BLG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 25 g Whey Protein Isolate (WPI)
Number of subjects: 16
Study: 32517498

Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-supervised exercise program
Number of subjects: 64
Study: 34895854

Group type: EXPERIMENTAL
Intervention: Local anaesthetic (chirocaine)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 20
Study: 34105063

Group type: EXPERIMENTAL
Intervention: Intramuscular paromomycin monotherapy (20 mg/kg for 21 days) in African patients
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Intramuscular paromomycin monotherapy (15 mg/kg for 21 days) in Indian patients
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Combination therapy (15 mg/kg for 17 days with sodium stibogluconate) in African patients
Number of subjects: 602
Study: 36037051

Group type: EXPERIMENTAL
Intervention: Communication intervention using a 5-step framework
Number of subjects: 47

Group type: COMPARATOR
Intervention: Pain management recommendations from the CDC (Control)
Number of subjects: 47
Study: 32628771

Group type: EXPERIMENTAL
Intervention: Reflectance confocal microscopy (RCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Punch biopsy (PB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patient satisfaction and preferences
Number of subjects: 0
Study: 35978380

Group type: EXPERIMENTAL
Intervention: Conventional shoulder musculoskeletal rehabilitation combined with aerobic exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solely conventional shoulder musculoskeletal rehabilitation
Number of subjects: 0
Study: 33947690

Group type: EXPERIMENTAL
Intervention: Veliparib throughout (240 mg BID for 14 days, then 400 mg BID maintenance)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Veliparib combination only (240 mg BID for 14 days, then placebo)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control (placebo plus chemotherapy followed by placebo)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Veliparib throughout in SLFN11-positive patients
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Veliparib throughout
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Veliparib combination only
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control
Number of subjects: 181
Study: 32436159

Group type: EXPERIMENTAL
Intervention: Intraoral scanner (group IS)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Control group (plaster casts digitized by a laboratory scanner, group ID)
Number of subjects: 690
Study: 35027302

Group type: EXPERIMENTAL
Intervention: Aromatherapy with inhaled lavender essential oil (n = 30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Breathing exercises (n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care (n = 30)
Number of subjects: 90
Study: 32031665

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80mg every 2 weeks (IXEQ2W)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80mg every 4 weeks (IXEQ4W)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Adalimumab 40mg every 2 weeks (ADA)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 417
Study: 32584996

Group type: EXPERIMENTAL
Intervention: Alendronate for 48 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate for an additional 48 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate after stopping treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32314290

Group type: EXPERIMENTAL
Intervention: Zataria multiflora extract 10 mg/kg/day (Z10)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Zataria multiflora extract 5 mg/kg/day (Z5)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 35836222

Group type: EXPERIMENTAL
Intervention: 8-week online intervention on healthy nutrition, physical activity, and wellbeing behaviours
Number of subjects: 2240

Group type: EXPERIMENTAL
Intervention: Booster sessions delivered during one class session in Grades 8 and 9
Number of subjects: 2240
Study: 33566107

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 33310163

Group type: EXPERIMENTAL
Intervention: Oxytocin augmentation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Delay in initiating oxytocin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Decision to deliver by CS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Time to delivery after CS decision
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Post-partum hemorrhage
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chorioamnionitis
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Surgical injury during intrapartum CS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peri-partum complications
Number of subjects: 60
Study: 34753185

Group type: EXPERIMENTAL
Intervention: Thyroxine therapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: HDP exposure
Number of subjects: 112

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 112
Study: 36474755

Group type: EXPERIMENTAL
Intervention: EP-104IAR (15 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 32
Study: 35120193

Group type: EXPERIMENTAL
Intervention: 80% oxygen
Number of subjects: 600

Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Antioxidants (3 g IV vitamin C and 100 mg/kg N‐acetylcysteine)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600

Group type: COMPARATOR
Intervention: Mortality at 30 days (80% vs. 30% oxygen)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Mortality at 30 days (antioxidants vs. placebo)
Number of subjects: 600
Study: 33547997

Group type: EXPERIMENTAL
Intervention: Active-fluidics system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Gravity-fluidics system
Number of subjects: 50
Study: 32406210

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT), 8.3 ± 2 sessions
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Baseline symptom severity
Number of subjects: 37
Study: 34480886

Group type: EXPERIMENTAL
Intervention: Inpatient Rehabilitation Facilities (IRFs)
Number of subjects: 400000

Group type: COMPARATOR
Intervention: Skilled Nursing Facilities (SNFs)
Number of subjects: 400000
Study: 34089920

Group type: EXPERIMENTAL
Intervention: Tangle
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Wobble cushion
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Earmuffs
Number of subjects: 271

Group type: COMPARATOR
Intervention: Nothing (control condition)
Number of subjects: 271
Study: 33006193

Group type: EXPERIMENTAL
Intervention: Multigrain flatbread
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 34985503

Group type: EXPERIMENTAL
Intervention: OCS Liver
Number of subjects: 300
Study: 34632601

Group type: EXPERIMENTAL
Intervention: Self-collected HPV testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Provider-collected HPV testing
Number of subjects: 0
Study: 35316091

Group type: EXPERIMENTAL
Intervention: Behavioral parent training intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 35655149

Group type: EXPERIMENTAL
Intervention: 12-week group CBT program (N = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-CBT control condition (N = 50)
Number of subjects: 100
Study: 32412700

Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg nasal spray twice-weekly for 4 weeks + standard-of-care treatment
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo nasal spray twice-weekly for 4 weeks + standard-of-care treatment
Number of subjects: 226
Study: 35085482

Group type: EXPERIMENTAL
Intervention: Rectal indometacin (100 mg) administered 30 min before ESWL
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Placebo (identical glycerin suppositories) administered 30 min before ESWL
Number of subjects: 1370

Group type: EXPERIMENTAL
Intervention: Rectal indometacin (100 mg)
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Placebo (identical glycerin suppositories)
Number of subjects: 1370
Study: 33670353

Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Program
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Positive Affect Promotion Program
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Mindfulness Program
Number of subjects: 164
Study: 36059913

Group type: EXPERIMENTAL
Intervention: Modified pouch technique (n: 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pouch technique (n: 8)
Number of subjects: 16
Study: 32381496

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC) at 3 L·kg‐1·min‐1
Number of subjects: 268

Group type: COMPARATOR
Intervention: Standard oxygen therapy (Control)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 268
Study: 35598164

Group type: EXPERIMENTAL
Intervention: Parent diabetes self‐efficacy
Number of subjects: 157

Group type: COMPARATOR
Intervention: Clinically elevated depressive symptoms and stress
Number of subjects: 157
Study: 33888900

Group type: EXPERIMENTAL
Intervention: 10 µg BNT162b1
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 30 µg BNT162b1
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 35092241

Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach to treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard therapy regimen
Number of subjects: 36
Study: 34813489

Group type: EXPERIMENTAL
Intervention: Videoconference-based cognitive behavioral therapy (vCBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 30
Study: 35318567

Group type: EXPERIMENTAL
Intervention: Gas Man® simulation using patient weight and the same FGF, vaporizer and minute ventilation settings
Number of subjects: 28
Study: 33537850

Group type: EXPERIMENTAL
Intervention: Trimanual vitrectomy with chandelier illumination, perfluorocarbon liquid (PFCL), and vital dyes.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bimanual vitrectomy with chandelier illumination only.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Trimanual vitrectomy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bimanual vitrectomy
Number of subjects: 36
Study: 32678767

Group type: EXPERIMENTAL
Intervention: Posterior wedge
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anterior-medial wedge
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lateral wedge
Number of subjects: 30
Study: 35470387

Group type: EXPERIMENTAL
Intervention: High load duration and intensity (75% maximal voluntary isometric contraction for 8 seconds)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Lower load duration and intensity (35% maximal voluntary isometric contraction for 2 seconds)
Number of subjects: 16
Study: 33051240

Group type: EXPERIMENTAL
Intervention: Autologous dendritic cell (DC) vaccines
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Blockade of ICOSL on DCs
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Extracellular/soluble ICOSL released from vaccine DCs
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ADAM10/17 sheddase activity
Number of subjects: 35
Study: 35756871

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with atorvastatin calcium tablets (20 mg/d for 15 days), traditional Chinese medicine (TCM) decoctions, and acupuncture therapy once daily for 15 days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atorvastatin calcium tablets (20 mg/d for 15 days)
Number of subjects: 0
Study: 34003164

Group type: EXPERIMENTAL
Intervention: Single-pulse transcranial magnetic stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supraorbital nerve stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote noncephalic electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External vagus nerve stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Number of subjects: 0
Study: 32465013

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3) LVAD
Number of subjects: 514
Study: 36892488

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Guideline Control
Number of subjects: 180
Study: 34179937

Group type: EXPERIMENTAL
Intervention: Fast walkers (gait speed > 1 m/sec)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Slow walkers (gait speed < 1 m/sec)
Number of subjects: 48
Study: 34843662

Group type: EXPERIMENTAL
Intervention: Attendees at the live indoor concert with comprehensive prevention strategy (antigen screening, medical mask wearing, optimized ventilation)
Number of subjects: 6678

Group type: COMPARATOR
Intervention: Non-attendees (control group)
Number of subjects: 6678
Study: 33661454

Group type: EXPERIMENTAL
Intervention: Loneliness (negatively phrased)
Number of subjects: 1377

Group type: EXPERIMENTAL
Intervention: Happiness (positively phrased)
Number of subjects: 1377

Group type: EXPERIMENTAL
Intervention: Activities (positively phrased)
Number of subjects: 1377

Group type: EXPERIMENTAL
Intervention: General response options interpretation
Number of subjects: 1377
Study: 32674250

Group type: EXPERIMENTAL
Intervention: 80 g/d oatmeal
Number of subjects: 62

Group type: COMPARATOR
Intervention: 80 g/d refined white rice
Number of subjects: 62
Study: 35569448

Group type: EXPERIMENTAL
Intervention: Awake prone positioning (n = 205)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care without prone positioning (control; n = 195)
Number of subjects: 400
Study: 34048528

Group type: EXPERIMENTAL
Intervention: Tool for Pharmacists to Predict 30-day hospital readmission in patients with Heart Failure (ToPP-HF)
Number of subjects: 3203
Study: 35834373

Group type: EXPERIMENTAL
Intervention: Screening strategy with machine learning risk prediction algorithm and diagnostic testing
Number of subjects: 3549300

Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 3549300
Study: 32162450

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) training sessions (6 sessions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (routine care only)
Number of subjects: 70
Study: 35637604

Group type: EXPERIMENTAL
Intervention: PVI without a waiting period (Group B)
Number of subjects: 167

Group type: COMPARATOR
Intervention: PVI with a waiting period of 20 min (Group A)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 167
Study: 34503541

Group type: EXPERIMENTAL
Intervention: Phosphocreatine disodium salts plus blueberry extract (PCDSB)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CM)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32731962

Group type: EXPERIMENTAL
Intervention: GII (1 additional feeder)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: GIII (2 additional feeders)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: GIV (3 additional feeders)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no additional feeders)
Number of subjects: 72
Study: 35360949

Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted bi-unicompartmental knee arthroplasty (bi-UKA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty (TKA)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted bi-UKA
Number of subjects: 76
Study: 33991868

Group type: EXPERIMENTAL
Intervention: Mobile application for treatment adherence and symptom management
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 77
Study: 36008246

Group type: EXPERIMENTAL
Intervention: Proprioceptive training program
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard conservative treatments
Number of subjects: 52
Study: 33737070

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatments
Number of subjects: 0
Study: 36454676

Group type: EXPERIMENTAL
Intervention: Load carriage treadmill exercise (30% body mass; 22.4 ± 3.7 kg)
Number of subjects: 20
Study: 34174551

Group type: EXPERIMENTAL
Intervention: High nicotine (0.5 mg) with low menthol (0.5%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Low nicotine (0.25 mg) with low menthol (0.5%)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Saline control (0.0 mg) with low menthol (0.5%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: High nicotine (0.5 mg) with saline control (0.0%)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Low nicotine (0.25 mg) with saline control (0.0%)
Number of subjects: 38